COVID-19 vaccinations do yield humoral immunogenicity in patients with rheumatoid arthritis, according to new data presented during the 2022 American College of Rheumatology Convergence Meeting in Philadelphia. A team, led by Esther Vicente-Rabaneda, Division of Rheumatology, Hospital Universitario de La Princesa, identified the efficacy and safety of the SARS-CoV-2 vaccine in a series of patients with rheumatoid arthritis. View More